On the public citation graph

Incremental Benefit of High-Dose Compared to Standard-Dose Vaccine in Reducing Influenza Hospitalizations

0 signed · 3 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.

Claim with ORCID

Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.

See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1056/evidoa2200206openalex-extracted

A Pragmatic Randomized Feasibility Trial of Influenza Vaccines

inferredcites →https://doi.org/10.1056/nejmoa1315727openalex-extracted

Efficacy of High-Dose versus Standard-Dose Influenza Vaccine in Older Adults

inferredcites →https://doi.org/10.1056/nejmoa2302099openalex-extracted

Recombinant or Standard-Dose Influenza Vaccine in Adults under 65 Years of Age

Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.